Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Brii Biosciences Broadens its Leadership in Hepatitis B with a Portfolio Now Addressing Disease's Burdens from Prevention to Cure 2023-07-06 07:25
Brii Biosciences Provides Latest Clinical Development and Corporate Updates 2023-07-06 07:19
AFTER FIVE YEARS OF SUCCESSFUL EXPERIENCE INTERNATIONALLY, BIOCON BIOLOGICS' HULIO® BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES 2023-07-04 01:22
Henlius Forecasts Profit in 1H 2023 2023-07-03 18:59
SHL Medical acquires 100% of the shares in Swiss company LCA Automation 2023-07-03 17:00
Innovent and IASO Bio Announce the NMPA Approval of FUCASO®, the First Fully-human BCMA CAR-T Therapy, for the Treatment of Relapsed or Refractory Multiple Myeloma 2023-07-03 08:00
Lifera and CENTOGENE, Enter Strategic Collaboration - Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing 2023-07-02 14:00
Transcenta Presented PFS Data by CLDN18.2 Expression Level from Phase I/II Study of Osemitamab (TST001) plus CAPOX as the First-Line Treatment of Advanced G/GEJ Cancer at ESMO GI Annual Congress 2023 2023-06-30 17:33
CPHI & PMEC China 2023 to launch international roadshow in Guangzhou 2023-06-29 18:10
Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore 2023-06-29 17:14
Nuance Pharma's Partner Verona Pharma Submits New Drug Application to US FDA for Ensifentrine for the Maintenance Treatment of COPD 2023-06-28 17:07
First Drug Discovered and Designed with Generative AI Enters Phase II Trials, with First Patients Dosed 2023-06-27 21:00
Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership 2023-06-27 15:33
Lion TCR Secures USD 40 million Series B2 Financing, Revolutionizing Solid Tumor Treatment with mRNA-Encoding TCR-T Cell Therapy 2023-06-27 08:30
CStone announces GAVRETO® (pralsetinib) sNDA approval by China NMPA for first-line treatment of patients with locally advanced or metastatic RET fusion-positive non-small cell lung cancer 2023-06-27 08:05
New ZIRCON Phase III Data Presented at SNMMI: Potential Utility of TLX250-CDx in Staging and Monitoring ccRCC 2023-06-27 03:51
Ascletis Announces Poster Presentation of Phase II Study of ASC42 FXR Agonist for Functional Cure of Chronic Hepatitis B at EASL CONGRESS 2023 2023-06-26 08:10
Innovent and RemeGen Enter into Clinical Trial Collaboration Investigating Combination Therapy of TYVYT® (sintilimab injection) and Novel ADC Candidates for Advanced Solid Tumors in China 2023-06-26 08:00
Brii Biosciences Announces Entry into Definitive Agreements from Sale of its Equity Interest in Qpex Biopharma and Acquiring Exclusive Global Rights for BRII-693 2023-06-26 07:30
Brii Bio Announces New Data from Partners Underscoring Potential for HBV Functional Cure at EASL™ Congress 2023 2023-06-25 20:00
1 29 30 31 32 33 230